With the opening of its building Imcheck Therapeutics enters into a new phase of growth

Located in the heart of the CNRS campus Joseph Aiguier near the Institut Paoli-Calmettes, the new headquarters of the company was inaugurated on 18 July by Dr. Debasish Roychowdhury and Pierre d’Epenoux, Chairman of the Board and CEO of the company. Thanks to this high-tech building, Imcheck Therapeutics intends to accelerate the development of its highly differentiated portfolio of first-in-class therapeutic antibodies originating from Pr. Daniel Olive’s lab.